लोड हो रहा है...
Risk of severe upper gastrointestinal complications among oral bisphosphonate users.
BACKGROUND: Oral bisphosphonates (BPs) are the primary agents for the treatment of osteoporosis. Although BPs are generally well tolerated, serious gastrointestinal adverse events have been observed. AIM: To assess the risk of severe upper gastrointestinal complications (UGIC) among BP users by mean...
में बचाया:
मुख्य लेखकों: | , , , , , , , , , , , , , , , |
---|---|
स्वरूप: | Artigo |
भाषा: | Inglês |
प्रकाशित: |
Public Library of Science (PLoS)
2013-01-01
|
श्रृंखला: | PLoS ONE |
ऑनलाइन पहुंच: | http://europepmc.org/articles/PMC3857168?pdf=render |
टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|